CF
COLL icon

Corebridge Financial’s Collegium Pharmaceutical COLL Stock Holding History

Corebridge Financial’s Portfolio COLL Stock Details COLL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-16,756
Closed -$500K – 618
2025
Q1 		$500K Sell
16,756
-328
-2% -$10K ﹤0.01% 1599
2024
Q4 		$489K Sell
17,084
-1,595
-9% -$52.8K ﹤0.01% 1698
2024
Q3 		$722K Sell
18,679
-218
-1% -$7.78K ﹤0.01% 1537
2024
Q2 		$608K Buy
+18,897
New +$655K ﹤0.01% 1586

Other funds holding COLL

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $187B AUM 18.48% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $29.7B AUM 43.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Corebridge Financial's COLL Position: Q2 2025 in Review

Corebridge Financial sold out of Collegium Pharmaceutical (COLL) in Q2 2025, closing a stake of 16,756 shares — an estimated $500K sold.

Corebridge Financial first reported a position in COLL in Q2 2024 and held it in 4 quarters. The position peaked at $722K in Q3 2024. 223 funds tracked by Wall St. Rank hold COLL as of Q2 2025.

  • Corebridge Financial reported no remaining Collegium Pharmaceutical position as of Q2 2025 after selling out during the quarter.
  • Corebridge Financial sold 16,756 Collegium Pharmaceutical shares in Q2 2025, an estimated $500K.
  • Corebridge Financial first reported a position in Collegium Pharmaceutical in Q2 2024 and held it in 4 quarters.
  • Corebridge Financial's Collegium Pharmaceutical position peaked at $722K in Q3 2024.
  • 223 funds tracked by Wall St. Rank held Collegium Pharmaceutical as of Q2 2025.

Based on Corebridge Financial's 13F filing for Q2 2025, filed 12 Aug 2025.